"Receptors, CXCR5" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
CXCR receptors isolated initially from BURKITT LYMPHOMA cells. CXCR5 receptors are expressed on mature, recirculating B-LYMPHOCYTES and are specific for CHEMOKINE CXCL13.
| Descriptor ID |
D054380
|
| MeSH Number(s) |
D12.776.543.750.695.160.500.500 D12.776.543.750.705.852.125.500.500
|
| Concept/Terms |
Receptors, CXCR5- Receptors, CXCR5
- CXC Chemokine Receptor 5
- CD185 Antigens
- Antigens, CD185
- CXCR5 Receptors
- Burkitt Lymphoma Receptor 1
|
Below are MeSH descriptors whose meaning is more general than "Receptors, CXCR5".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Chemokine [D12.776.543.750.695.160]
- Receptors, CXCR [D12.776.543.750.695.160.500]
- Receptors, CXCR5 [D12.776.543.750.695.160.500.500]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Chemokine [D12.776.543.750.705.852.125]
- Receptors, CXCR [D12.776.543.750.705.852.125.500]
- Receptors, CXCR5 [D12.776.543.750.705.852.125.500.500]
Below are MeSH descriptors whose meaning is more specific than "Receptors, CXCR5".
This graph shows the total number of publications written about "Receptors, CXCR5" by people in this website by year, and whether "Receptors, CXCR5" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, CXCR5" by people in Profiles.
-
The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13. Blood. 2021 11 11; 138(19):1870-1884.
-
Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis. Nature. 2019 06; 570(7762):528-532.
-
Pneumocystis-Driven Inducible Bronchus-Associated Lymphoid Tissue Formation Requires Th2 and Th17 Immunity. Cell Rep. 2017 03 28; 18(13):3078-3090.
-
Altered Expression of CXCL13 and CXCR5 in Intractable Temporal Lobe Epilepsy Patients and Pilocarpine-Induced Epileptic Rats. Neurochem Res. 2017 Feb; 42(2):526-540.
-
Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol. 2013 Sep; 6(5):972-84.
-
CXCR5? T helper cells mediate protective immunity against tuberculosis. J Clin Invest. 2013 Feb; 123(2):712-26.
-
B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion. J Immunol. 2002 May 15; 168(10):5117-23.